Taro Pharmaceutical Industries Overview

Taro Pharmaceutical Industries EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TARO.

Quarterly EBIT

$9.84M

↑ 6.11% YoY

As of Mar 31, 2024

Annual EBIT (TTM)

$21.94M

↑ 11.03% YoY

Trailing 12 months ending Mar 31, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin